Pagination not final/Pagination non finale
6
Can. J. Chem. Vol. 87, 2009
4.20 [t, J(H–H) = 5.0, 2H, Hc], {6.34–6.36 [m, 2H], 6.80 [t,
J(H–H) = 8.0, 2H], 6.89–6.92 [m, 3H], 7.12 [d, J(H–H) =
8.4, 2H], 7.44–7.46 [m, 3H], 8.12 [d, J(H–H) = 8.0, 2H],
[PtMe2{4-(2′-C5H4N)C6H4CHNCH2CH2NMe2}] (2aMe)
Compound 2aMe was obtained from 88 mg (3.49 ×
10–4 mol) of ligand 1a and 100 mg (1.74 × 10–4 mol) of
compound [Pt2Me4(µ-SMe2)2] in acetone (20 mL). The mix-
ture was stirred for 30 min at room temperature. 2aMe was
obtained as an orange solid upon removal of the acetone in a
rotary evaporator and washing of the residue with ether (3 ×
2 mL).
3
8.81 [s, 2H], 9.20 [s, 1H], aromatics}, 8.87 [s, J(Pt–H) =
43, 1H, Hd]. ES (+)-MS (MeCN – H2O): 604 [M + H], 526
[M – Ph], 449 [M – 2Ph]. Anal. found: C, 53.2; H, 4.8; N,
9.0. Calcd. for C27H28N4Pt: C, 53.72; H, 4.67; N, 9.28 (%).
1
[PtCl2{4-(2′-C5H4N)C6H4CHNCH2CH2NMe2}] (2aCl)
Compound 2aCl was obtained from 150 mg (3.50 ×
10–4 mol) of cis-[PtCl2(DMSO)2] and the equimolar amount
(90.0 mg) of 1a after refluxing the mixture in methanol for
5 h. On cooling, a light yellow solid is formed.
Yield: 150 mg (90%). H NMR (400 MHz, CDCl3) δ:
2
2
0.25 [s, J(Pt–H) = 90, 3H, Hk], 0.63 [s, J(Pt–H) = 84, 3H,
Hl], 2.71 [t, J(H–H) = 5.2, 2H, Hb], 2.84 [s, J(H–Pt) = 19,
3
6H, Ha], 4.07 [t, J(H–H) = 5.2, 2H, Hc], 7.76–7.79 [m, 3H,
Hh,i,j], {8.01 [d, J(H–H) = 8.2, 2H], 8.37 [d, J(H–H) = 8.2,
1
2H],He,f}, 8.70 [d, J(H–H) = 5.2, 1H, Hg], 9.03 [s, J(Pt–
3
Yield: 120 mg (65%). H NMR (400 MHz, CDCl3) δ:
2
2.70 [t, J(H–H) = 6.0, 2H, Hb], 3.14 [s, 6H, Mea], 4.09 [td,
H) = 45, 1H, Hd]. ES (+)-MS (MeCN – H2O): 504 [M – Me +
MeCN], 489 [M – 2Me + MeCN], 463 [M – Me], 448 [M –
2Me]. Anal. found: C, 44.5; H, 5.9; N, 8.5. Calcd. for
C18H25N3Pt: C, 45.18; H, 5.26; N, 8.78 (%).
2J(H–H) = 6.0, 2.0, 2H, Hc], 7.33 [ddd, J(H–H) = 6.8, 4.8, 2,
3
1H, Hh], 7.64 [d, J(H–H) = 8.4, 2H, He or Hf], 7.80–7.82
3
[m, 2H, Hi, Hj], 8.13 [d, J(H–H) = 8.4, 2H, He or Hf], 8.73
3
[dt, J(H–H) = 4.8, 2, 1H, Hg], 9.58 [s, J(Pt–H) = 52, 1H,
Hd]. ESI-MS: 520 [M + H], 484 [M – Cl]. Anal. found: C,
36.2; H, 3.7; N, 8.0. Calcd. for C16H19Cl2N3Pt·H2O: C,
35.76; H, 3.94; N, 7.82 (%).
[PtMe2{4-(3′,5′-C4H3N2)C6H4CHNCH2CH2NMe2}] (2bMe)
Compound 2bMe was obtained following the same proce-
dure from 18 mg of ligand 1b and 20 mg (0.35 × 10–4 mol)
of compound [Pt2Me4(µ-SMe2)2] in acetone (10 mL). Com-
pound 2bMe could be characterized in solution, and within
an hour, produces 3bMe (see below).
[PtCl2{4-(3′,5′-C4H3N)C6H4CHNCH2CH2NMe2}] (2bCl)
Compound 2bCl was obtained as an insoluble impure
solid following the procedure reported above for 2aCl.
1H NMR (400 MHz, CDCl3) δ: 2.72 [m, 2H, Hb], 3.15 [s,
2
1H NMR (400 MHz, CDCl3) δ: 0.21 [s, J(Pt–H) = 90,
2
3H, Hi], 0.64 [s, J(Pt–H) = 84, 3H, Hj], 2.72 [m, 2H, Hb],
2
6H, Mea], 4.08 [t J(H–H) = 6.0, 2H, Hc], 7.73–7.76 [m,
3
2.85 [s, J(H–Pt) = 20, 6H, Ha], 4.11 [m, 2H, Hc], {7.60 [d,
4H], 8.99 [s, 2H,], 9.29 [s, 1H], 9.57 [s, 1H, Hd].
J(H–H) = 8.4, 2H], 8.45 [d, J(H–H) = 8.4, 2H], He,f}, 9.00
3
[s, 2H, Hg], 9.07 [s, J(Pt–H) = 42, 1H, Hd], 9.24 [s, 1H,
Hh].
[PtMe{4-(2′-C5H4N)C6H3CHNCH2CH2NMe2}] (3aMe)
Compound 3aMe was obtained after refluxing a toluene
solution (20 mL) containing 50 mg of compound 2aMe for
2 h. Toluene was totally removed, and the residue was
recrystallized from CH2Cl2–MeOH to yield 3aMe as a red
solid.
[PtPh2{4-(2′-C5H4N)C6H4CHNCH2CH2NMe2}] (2aPh)
Compound 2aPh was obtained as a yellow solid following
the same procedure as for 2aMe from 48 mg (0.19 mmol) of
ligand 1a and the equimolar amount of compound cis-
[PtPh2(SMe2)2] (90 mg) in acetone (10 mL).
1
Yield: 40 mg (83%). H NMR (400 MHz, CDCl3) δ: 1.06
[s, J(Pt–H) = 79, 3H, Hl], 2.86 [s, J(H–Pt) = 20, 6H, Ha],
3.19 [t, J(H–H) = 5.2, 2H, Hb], 4.09 [t, J(H–H) = 5.2, 2H,
Hc], 7.19 [m, 2H, Hi,j], {7.37 [d, J(H–H) = 8.0, 2H], 7.82 [d,
J(H–H) = 8.0, 2H],He,f}, 7.73 [d, J(H–H) = 6.8, 1H, Hk],
1
2
3
Yield: 80 mg (70%). H NMR (400 MHz, CDCl3) δ: 2.67
3
[s, J(Pt–H) = 17, 6H, Mea], 2.79 [t, J(H–H) = 5.0, 2H, Hb],
4.21 [t, J(H–H) = 5.0, 2H, Hc], {6.28 [t, J(H–H) = 7.0, 1H],
6.38 [t, J(H–H) = 7.4, 2H], 6.81 [t, J(H–H) = 7.2, 1H], 6.93
[m, 4H], 7.23 [ddd, J(H–H) = 7.6, 4.8, 1.2, 1H], 7.48 [d,
J(H–H) = 8.0, 2H], 7.55–7.58 [m, 3H], 7.73 [td, J(H–H) =
7.6, 2, 1H], 8.14 [d, J(H–H) = 8.4, 2H], 8.65 [ddd, J(H–H) =
8.07 [d, J(H–H) = 2, J(Pt–H) = 67, 1H, Hg], 8.64 [s, J(H–
Pt) = 58, 1H, Hd], 8.67 [d, J(H–H) = 4.8, 1H, Hh]. ES (+)-
MS (MeCN – H2O): 488 [M – Me + MeCN], 462 [M]. Anal.
found: C, 44.0; H, 4.7; N, 8.5. Calcd. for C17H21N3Pt: C,
44.15; H, 4.58; N, 9.09 (%).
3
3
3
4.4, 1.6, 1.0, 1H]}, 8.84 [s, J(Pt–H) = 44, 1H, Hd]. ES (+)-
MS (MeCN – H2O): 603 [M + H], 525 [M – Ph], 448 [M –
2Ph]. Anal. found: C, 54.5; H, 4.9; N, 6.5. Calcd. for
C28H29N3Pt·H2O: C, 54.18; H, 5.03; N, 6.77 (%).
Isomerization to 2a′Ph (Z isomer) took place in acetone at
[PtMe{4-(3′,5′-C4H3N2)C6H3CHNCH2CH2NMe2}] (3bMe)
Compound 3bMe was obtained from 89 mg (3.49 ×
10–4 mol) of ligand 1b and 100 mg (1.74 × 10–4 mol) of
compound [Pt2Me4(µ-SMe2)2] in acetone (20 mL). The mix-
ture was stirred for 1 h at room temperature, metallic plati-
num was filtered off, and acetone was removed in a rotary
evaporator. Red crystals of 3bMe were obtained upon
recrystallization of the residue from CH2Cl2–MeOH.
1
room temperature. H NMR (400 MHz, CDCl3) δ: 2.62 [s,
2J(Pt–H) = 21, 6H, Mea], 2.76 [t, J(H–H) = 6.0, 2H, Hb],
3
4.02 [td, J(H–H) = 6.0, 2,0, 2H, Hc], 8.43 [s, J(Pt–H) = 28,
1H, Hd].
[PtPh2{4-(3′,5′-C4H3N2)C6H4CHNCH2CH2NMe2}}] (2bPh)
Compound 2bPh was obtained as a yellow solid following
the same procedure as for 2aMe from 48.3 mg (0.19 mmol)
of ligand 1b and the equimolar amount of compound cis-
[PtPh2(SMe2)2] (90 mg) in acetone (10 mL).
1
Yield: 100 mg (62%). H NMR (400 MHz, CDCl3) δ:
2
3
1.04 [s, J(Pt–H) = 78, 3H, Hj], 2.87 [s, J(H–Pt) = 21, 6H,
Ha], 3.21 [t, J(H–H) = 6.0, 2H, Hb], 4.12 [td, J(H–H) = 6.0,
1.2, 2H, Hc], 7.16 [dd, J(H–H) = 7.6, 1.6, 1H, Hf], 7.38 [d,
1
4
Yield: 90 mg (78%). H NMR (400 MHz, CDCl3) δ: 2.67
J(H–H) = 7.6, J(H–Pt) = 10, 1H, He], 7.82 [d, J(H–H) =
[s, J(Pt–H) = 18, 6H, Mea], 2.80 [t, J(H–H) = 5.0, 2H, Hb],
2.0, 3J(H–Pt) = 65, 1H, Hg], 8.68 [s, 3J(H–Pt) = 59, 1H, Hd],
3
© 2008 NRC Canada